Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Schwetz, I; Domej, W; Krause, R.
Invasive candidiasis in the critically ill, patient non-neutropenic
Wien Med Wochenschr. 2007; 157(19-20): 490-492.
Doi: 10.1007/s10354-007-0464-0
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Krause Robert
- Zollner-Schwetz Ines
- Co-authors Med Uni Graz
- Domej Wolfgang
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Invasive candidiasis can occur in immunosuppressed patients as well as in critically ill, non-immunocompromised patients and is associated with high mortality (20-40 %). Intestinal Candida colonisation is an important source for invasive candidiasis. Risk factors for the development of invasive candidiasis include presence of an intravascular device, organ dysfunction, impaired mucosal or skin barrier function, therapy with antacids or corticosteroids, prolonged stay at the ICU, total parenteral nutrition and prolonged antibiotic therapy. Among patients with invasive candidiasis, antifungal treatment should be started without delay. Antifungal prophylaxis is currently not recommended in critically ill, non-immunocompromised patients.
- Find related publications in this database (using NLM MeSH Indexing)
- Antifungal Agents - therapeutic use
- Candidiasis - diagnosis
- Critical Illness - diagnosis
- Cross Infection - diagnosis
- Fungemia - diagnosis
- Humans - diagnosis
- Intensive Care Units - diagnosis
- Intestinal Mucosa - microbiology
- Neutropenia - diagnosis
- Opportunistic Infections - diagnosis
- Risk Factors - diagnosis